A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

NCT07013474 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Infection

Interventions

DRUG: ibuzatrelvir
DRUG: remdesivir
DRUG: placebo for ibuzatrelvir
DRUG: placebo for remdesivir

Sponsor

Pfizer